For in-vitro research use only. Not for human consumption.
AOD9604
AOD9604 is a modified 16-amino acid peptide fragment corresponding to the C-terminal region of human growth hormone (amino acids 176-191). It was specifically designed to isolate the lipolytic activity of hGH while excluding somatotropic effects. Research has examined its interaction with beta-3 adrenergic receptor signaling and fat metabolism pathways.
AOD9604 definition
AOD9604 is a modified 16-amino acid peptide fragment corresponding to the C-terminal region of human growth hormone (amino acids 176-191). It was specifically designed to isolate the lipolytic activity of hGH while excluding somatotropic effects. Research has examined its interaction with beta-3 adrenergic receptor signaling and fat metabolism pathways.
No sequence is listed in the current catalog record for this product.
- CAS
- 221231-10-3
- MW
- 1815.08 g/mol
- Sequence
- Not listed
- Half-life
- Not listed
- Formula
- C78H123N23O23S2
- Purity
- 99.63%
- Form
- Lyophilized powder
- Class
- Modified hGH Fragment
Reconstitution calculator
Estimate vial concentration and aliquot volume from the selected vial mass, solvent volume, and target research amount.
Calculations are for lab planning only and do not replace the product COA, protocol requirements, or qualified professional review. Confirm solvent compatibility before use.
Compound details.
- CAS Number
- 221231-10-3
- Molecular Weight
- 1815.08 g/mol
- Molecular Formula
- C₇₈H₁₂₃N₂₃O₂₃S₂
- Class
- Modified hGH Fragment
- Purity
- ≥99% purity
- Physical Form
- Lyophilized powder
- Storage
- Store at -20°C (long term). Refrigerate after reconstitution.
Research context.
Originally developed by Metabolic Pharmaceuticals and studied at Monash University, AOD9604 has been investigated in adipose tissue metabolism research. Published studies have explored its effects on lipogenesis inhibition and lipolysis stimulation in adipocyte models. It received GRAS (Generally Recognized as Safe) status from the FDA as a food ingredient in 2011.
Verification standard.
Every Nexus Laboratory batch ships with a Certificate of Analysis documenting HPLC purity (target ≥98%), mass spectrometry identity (expected versus observed mass), and endotoxin screening — verified by third-party laboratory testing and publicly archived. Review Nexus lab verification.
AOD9604 is part of the Nexus Specialty Research catalog. Specialized compounds outside the larger peptide families. Each listed variant is priced from the consolidated Nexus catalog and intended for qualified research use only.
TODO-COPY: replace with real compound-specific narrative.
The chemistry.
16-amino acid fragment of human growth hormone (hGH 176-191) with an N-terminal tyrosine
Storage: Store at -20°C (long term). Refrigerate after reconstitution.
Technical specifications.
- Product Name: AOD9604
- Classification: Modified hGH Fragment
- Structural Description: 16-amino acid fragment of human growth hormone (hGH 176-191) with an N-terminal tyrosine
- CAS Number: 221231-10-3
- Molecular Weight: 1815.08 g/mol
- Purity: ≥99% (verified by HPLC and Mass Spectrometry)
- Physical Form: Lyophilized (freeze-dried) powder
- Intended Use: In-vitro research use only — not for human consumption
HPLC trace preview.
Related research compounds
Same category, mechanism overlap, and common research stack pairings.
AOD9604 research FAQ.
What is AOD9604 used for in research?
AOD9604 is supplied for controlled in-vitro research workflows in the Specialty Research category. It is not labeled for human or veterinary use.
Is AOD9604 HPLC verified?
AOD9604 is listed with Nexus lab verification. Current catalog records show 99.63% purity context where batch COA data is available.
Which AOD9604 sizes are available?
Current Nexus variants include 2mg, 5mg, 10mg.
Does AOD9604 include a COA?
Yes. The current Nexus record links AOD9604 to batch NEX-AOD9604-2026-0008.